Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: Decrease followed by resurgence

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 7, 2012, Pages 429-436

  Yeom, Joon Sup ^a   Jun, Gyo ^b   Kim, Jung Yeon ^c   Lee, Won Ja ^c   Shin, E Hyun ^c   Chang, Kyu Sik ^c   Bang, Ji Hwan ^d   Oh, Sejoong ^e   Kang, Joon Young ^b   Park, Jae Won ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gachon University   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

^d National Medical Center   (South Korea)

^e Korean Armed Forces Medical Command   (South Korea)

Author keywords

Chemoprevention; Democratic People's Republic of Korea; Epidemiology; Malaria; Plasmodium vivax; Republic of Korea

Indexed keywords

CHLOROQUINE; PRIMAQUINE;

ANTIMICROBIAL THERAPY; ARTICLE; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; HUMAN; KOREA; MAJOR CLINICAL STUDY; PARASITE CLEARANCE; PLASMODIUM VIVAX MALARIA; SOLDIER; VETERAN;

ANTIMALARIALS; CHEMOPREVENTION; DISEASE OUTBREAKS; DRUG RESISTANCE; FEMALE; HUMANS; INCIDENCE; MALARIA, VIVAX; MALE; MILITARY PERSONNEL; PLASMODIUM VIVAX; PRIMAQUINE; RECURRENCE; REPUBLIC OF KOREA; VETERANS;

PLASMODIUM VIVAX;

EID: 84862121347     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.03.011     Document Type: Article

References (21)

1. Sinden R.E., Gilles H.M. The malaria parasites. Essential Malariology 2002, 8-34. Arnold Press, London. 4th ed. D.A. Warrell, H.M. Gilles (Eds.).
2. WHO. World malaria report 2010. Geneva: World Health Organization; 2010. [accessed 2 May 2011]. http://www.who.int/malaria/world_malaria_report_2010/worldmalariareport2010.pdf.
3. WHO Synopsis of the world malaria situation in 1979. Wkly Epidemiol Rec 1981, 56:145-149.
4. Park J.W., Klein T.A., Lee H.C., et al. Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg 2003, 69:159-167.
5. Yeom J.S., Ryu S.H., Oh S., et al. Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003. Am J Trop Med Hyg 2005, 73:604-608.
6. Yeom J.S., Kim T.S., Oh S., et al. Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection. Am J Trop Med Hyg 2007, 76:865-868.
7. Jun G., Yeom J.S., Hong J.Y., et al. Resurgence of Plasmodium vivax malaria in the Republic of Korea during 2006-2007. Am J Trop Med Hyg 2009, 81:605-610.
8. Park J.W., Jun G., Yeom J.S. Plasmodium vivax malaria: Status in the Republic of Korea following reemergence. Korean J Parasitol 2009, 47:S39-S50.
9. Yeom J.S., Ryu S.H., Oh S., et al. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea Army. J Korean Med Sci 2005, 20:707-712.
10. Lim H.S., Im J.S., Cho J.Y., et al. Pharmacokinetics of hydroxychloroquine and its clinical implications in the chemoprophylaxis against vivax malaria. Antimicrob Agents Chemother 2009, 53:1468-1475.
11. Lee K.S., Kim T.H., Kim E.S., et al. Chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 2009, 80:215-217.
12. Lee W.J., Klein T.A., Kim H.C., et al. Anopheles kleini, Anopheles pullus, and Anopheles sinensis: Potential vectors of Plasmodium vivax in the Republic of Korea. J Med Entomol 2007, 44:1086-1090.
13. Lee H.W., Shin E.H., Cho S.H., et al. Detection of vivax malaria sporozoites naturally infected in Anopheline mosquitoes from endemic areas of northern parts of Gyeonggi-do (Province) in Korea. Korean J Parasitol 2002, 40:75-81.
14. Oh S.S., Hur M.J., Joo G.S., et al. Vector surveillance in Ganghwa-do, a malaria-endemic area in the Republic of Korea. Korean J Parasitol 2010, 48:35-41.
15. Hankey D.D., Jones R., Coatney G.R., et al. Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg 1953, 2:958-969.
16. Korea Centers for Disease Control and Prevention. Establishment of a system to prevent endemicization of vivax malaria in the Republic of Korea (in Korean). Seoul: Korea Centers for Disease Control and Prevention; 2010.
17. Coatney G.R., Alving A.S., Jones R., et al. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 1953, 2:985-988.
18. Jones R., Jackson L.S., Lorenzo A.D., et al. Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg daily. Am J Trop Med Hyg 1953, 2:977-982.
19. WHO Regional Office for South-East Asia. Inter-regional meeting on vivax malaria in Asia. Report of the Meeting 23-24 April 2009. New Delhi: Regional Office for South-East Asia, World Health Organization; 2009. SEA-Mal-261.
20. Korea Centers for Disease Control and Prevention. Interim evaluation of efficacy of 2010 malaria eradication project (in Korean). Seoul: Korea Centers for Disease Control and Prevention; 2008.
21. Park J.W. Changing transmission pattern of Plasmodium vivax malaria in the Republic of Korea: Relationship with climate change. Environ Health Toxicol 2011, 26:1-6.